The magic pen creature delivers good news again! Recently, Shenbi Biotech successfully completed a multi-million-level angel + round of financing. This round of investment was exclusively added by Meihua Venture Capital. The smooth progress of this financing further demonstrates the market and capital institutions' high recognition of Shenbi Bio's innovation and development potential.
Since its establishment, Shenbi Biotech has always focused on promoting plant genetic improvement through high-throughput gene editing technology, and is committed to creating high-brightness luminescent plants to fill many gaps in the domestic biotechnology field. Our core technology broke through the bottleneck of low luminous efficiency of traditional plants and successfully created the first high-brightness self-luminous plant, which has attracted widespread attention from society and been reported by many authoritative official media such as CCTV1, CCTV13, and CCTV News.
The success of this financing marks another solid step taken by Shenbi Biotech on the road of innovation. We will continue to increase investment in research and development, expand market cooperation, promote the commercial application of scientific and technological achievements through the establishment of online platforms and offline multi-channel sales channels, and accelerate the popularization and promotion of plant gene editing technology in more fields.
January 13, 2026
January 13, 2026
January 13, 2026